U.S. Markets open in 7 hrs 24 mins

Clovis Oncology, Inc. (CLVS)

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Add to watchlist
76.01-0.73 (-0.95%)
At close: 4:00PM EDT
People also watch
TSROPBYIKITEBLUESRPT
  • B
    B
    B
    Looks like recovering well...
  • B
    B
    B
    here we go!
    Imageyourreactiongifs
  • j
    johnm
    johnm
    I was looking for some type of confirmation that maybe Lilly is interested in Clovis. The October 27 puts with a strike price of 75 are much more active than any other put or call for that matter. Someone or some people feel Lilly will be below 75 by the end of October and that is taking into consideration the positive news that has come out lately on Lilly. Taking on debt or issuing more shares to finance a takeover could be the reason. Maybe there is some truth to the pending LLY-CLVS takeover.
  • j
    johnm
    johnm
    Any serious buyout talk should start at $8 billion and nothing less. If this company gets sold for $6 billion it will be the steal of the century. Just saying....GLTA longs
  • E
    Edgutie
    Edgutie
    After hours buyout announcements coming!!! The big boys got prior leaks already.
  • S
    Sean
    Sean
    oh man, I sold half at 71 this morning... so mad... well, at least i still have 1/2
  • E
    Edgutie
    Edgutie
    I would not be surprise if after all, Clovis turns out to be the big winner of all. Potentially creating a bidding war among the big pharma players such as Gilead, Elly, etc......I can think of so many companies that will benefit from this buyout. Even at current level, Clovis still cheap.......over half of Billions in cash, little debt and lable expansion on the way.
  • E
    Erina
    Erina
    The simple rule: any company with an approved oncology drug is a $3B+ company.
    The PARPi field is wide opened since Ovarian cancer (OC) monotherapy is just a beginning with various other cancers (prostate, breast, lung, etc) and combos to follow.
    GILD just paid for KITE a fortune. CAR-T science is not there with the commercially unattractive drug administration. Finally, CAR-T drugs are extremely toxic making marketing a very tricky business.
  • c
    cheryl
    cheryl
    Nice volume at the $110 strike
  • J
    JohnnyB
    JohnnyB
    what happened ?
  • j
    johnm
    johnm
    I do not see takeover price at $110 dollars. That is way to cheap, a the company has $500 million in cash to spend on studies and marketing. Nothing less than $8 billion in a takeover which is about $155 per share. Negotiations take time so don't expect the deal to be consummated today. Mid October more likely.
  • B
    B
    B
    Takeover rumor du jour: Clovis by Lilly
    Clovis Oncology (CLVS +6.1%) perks up on light volume amidst chatter that Eli Lilly (LLY -0.3%) is mulling a bid.The company recently announced positive results from a late-stage study assessing lead
    seekingalpha.com
  • M
    Michael
    Michael
    Here comes the squeezed 💪
  • G
    Guy
    Guy
    Crossing the 80 $ mark will be a positive sign that we are indeed heading north...
  • R
    Richard
    Richard
    1r0 to 155
  • B
    B
    B
    Buyout is inevitable. They have the best-in-class drug. They are also the cheapest compared to competitors. Perfect combination.
    Imageabritandayank
  • b
    brad
    brad
    wow
  • M
    Michael
    Michael
    5 4 3 2 1 - We have LIFTOFF!!!!!!!!!!!!!!!!
  • E
    Edgutie
    Edgutie
    Buyout......whether or not this time goes through, we all know, it is just a matter of time.
  • L
    LegalMonster
    LegalMonster
    After weeks of $3 to $5 daily price movements, today's price action makes it clear MMs and Tutes will control price in tight range to wipe out all the thousands of options contracts expiring today.